Three weeks after InnoCare launched its IPO into the welcoming embrace of HKEX investors, Akesobio is looking to one-up the company with its own $300 million (HKD$2.34 billion) raise.
Partnered with Merck, Akesobio’s pitch centers around a suite of in-… […]
→ The nonprofit Wellcome is looking to raise $8 billion to fund the development of new drugs and vaccines that can fight Covid-19. The UK organization says that represents just a fraction of the money that’s been set aside to safeguard economies and wo… […]
The cuts underscore that not even digital health — an industry whose offerings are in high demand during the crisis — is immune to an unprecedented financial meltdown. […]
SAN FRANCISCO–(BUSINESS WIRE)– #ai–Pluto7, a Google Cloud Premier Partner in North America and India received the 2019 Google Cloud Specialization Partner of the Year Award for Data and Analytics. Pluto7 has been awarded this prestigious honor for i… […]
Biotech in the time of coronavirus: Will #JPM21 be a thing? […]
SAN JOSE, Calif.–(BUSINESS WIRE)–Mendel, the leader in clinical AI technologies, announced the launch of a new search engine using proprietary AI to absorb more than 50,000 coronavirus research papers and answer questions related to COVID-19. DCM, a … […]
A month after he first gathered Big Pharma and big biotech executives around a table at the White House, President Trump held a conference call yesterday with executives from four different drugmakers pursuing treatments for Covid-19: Regeneron, Genent… […]
In what had been shaping up to be a major year for microbiome biotechs, Gilead is getting in on the action.
America’s newly most watched big biotech announced a four-year, $38 million upfront pact with Second Genome to identify biomarkers that can meas… […]
The money keeps pouring in for protein degradation.
A field that six years ago had the financial equivalent of tumbleweed is now flush with cash. Last month, a pair of biotechs, now backed with big pharma and big biotech deals, landed a total of $222 … […]
SOUTH SAN FRANCISCO, Calif., April 06, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active … […]
© 2020 San Francisco Biotechnology Network
